A state initiative to reduce intermediaries in China’s pharmaceutical market is expected to more than halve the number of companies in the sector, but experts say the government will struggle to achieve its aim of cutting drug prices and tackling bribery in distribution chains.
manbetx3.0 政府一项缩减医药市场中间环节的计划，有望使该领域的企业数量减少一半以上，但专家们表示，政府将很难实现其压低药价、清除分销链条中贿赂行为的目标。
您已阅读7%（351字），剩余93%（4825字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。